نتایج جستجو برای: glucose transporter type 2

تعداد نتایج: 3593884  

2010
Shyny Koshy Parema Alizadeh Lubov T. Timchenko Christine Beeton

Glucose is the main source of energy for the body, requiring constant regulation of its blood concentration. Insulin release by the pancreas induces glucose uptake by insulin-sensitive tissues, most notably the brain, skeletal muscle, and adipocytes. Patients suffering from type-2 diabetes and/or obesity often develop insulin resistance and are unable to control their glucose homeostasis. New i...

Journal: :Pharmaceutical Journal of Indonesia 2021

Diabetes Mellitus (DM) is an incurable disease that can be prevented clinically from worsening. This based on classification related to pancreatic damage in total or partial so the impact insulin production. Glucose transporter a protein glucose uptake outside cell into and provides important role body's homeostasis. transporter-2 (GLUT-2) found pancreas, liver, kidney. Parameters used are expr...

Journal: :Kidney International Reports 2023

Sodium-glucose co-transporter 2 (SGLT2) inhibitors may decrease risk of renal function deterioration and proteinuria progression but, there are little clinical data about the comparison between dapagliflozin (DAPA) versus empagliflozin (EMPA) in patients with diabetes mellitus (DM) over one year time. Inhere,we directly compare effectiveness two distinct sodium-glucose co-transporter2 (SGLT2I) ...

Journal: :FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1994
A Klip T Tsakiridis A Marette P A Ortiz

Glucose transporters are membrane-embedded proteins that mediate the uptake of glucose from the surrounding medium into the cell. Glucose is the main fuel for most cells, and its uptake is rate-limiting for glucose utilization. For this reason, it is expected that glucose transport is tightly regulated. Whereas rapid regulation of glucose transporters by hormones has been known for some time, t...

Journal: :iranian journal of diabetes and obesity 0
fatemeh azizi soleiman ms in nutrition science, food security research center, department of community nutrition, isfahan university of medical science, isfahan, iran. naseh pahlavani ms in nutrition science, food security research center, department of clinical nutrition, isfahan university of medical science, isfahan, iran. hamid rasad ms in nutrition science, food security research center, department of community nutrition, isfahan university of medical science, isfahan, iran. omid sadeghi ms in nutrition science, food security research center, department of community nutrition, isfahan university of medical science, isfahan, iran. mahmood reza gohari assistant professor. faculty of management, tehran university of medical sciences, tehran, iran.

abstract objective: globally, 3-5.2 percent of people suffer from diabetes which is one of the most serious metabolic disorders resulting in an increase in inflammatory biomarkers e.g. interleukin-6, tumor necrosis factor-alpha, and c-reactive protein. the aim of this study was to investigate the relationship between inflammation, oxidative stress and fasting blood glucose, lipid profile and an...

Journal: :پژوهنده 0
سمیه حسین پور نیازی somayeh hosseinpour-niazi ، دکتر پروین میرمیران parvin mirmiran department of nutrition and clinical dietetics, faculty of nutrition sciences and food technology, national nutrition and food technology research institute, shahid beheshti university of medical sciences, tehran, iranگروه آموزشی تغذیه ی بالینی و رژیم درمانی، دانشکده علوم تغذیه و صنایع غذایی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران دکتر مهدی هدایتی mehdi hedayati دکتر فریدون عزیزی fereidoun azizi سحر میرزایی sahar mirzaei

background and aim: the aim of this study was to determine the effect of legume intake in therapeutic lifestyle change (tlc) on fasting insulin, fasting blood glucose, hba1c and homeostasis model assessment insulin resistance (homa-ir) in patients with type 2 diabetes. materials and methods: in this randomized crossover trial, 31 subjects with type 2 diabetes in the age range of 50 to 80 years ...

Journal: :Handbook of experimental pharmacology 2011
Rolf K H Kinne Francisco Castaneda

Recently, the idea has been developed to lower blood glucose blood glucose levels in diabetes by inhibiting sugar reabsorption sugar reabsorption in the kidney kidney . The main target is thereby the early proximal tubule proximal tubule where secondary active transport secondary active transport of the sugar is mediated by the sodium-D: -glucose D-glucose cotransporter SGLT2 SGLT2 . A model su...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید